Trump Fast-Tracks Psychedelics Research for Vets

0:00President Trump just signed an executive order pushing his administration to fast-track reviews on psychedelics like eyeball gain, a drug-gaining traction, with combat vets and some conservative leaders for treating tough mental health issues. These substances sit in the strictest federal ban category right now, labeled high-risk and illegal. But the move aims to ramp up research for conditions like severe depression, post-traumatic stress disorder, and opioid addiction, giving sufferers A, shot at new treatments. Vets and advocates have pushed hard for this, saying eyeball gain from a West African plant shows real promise even as it carries serious risks like heart rhythm problems linked to over 30 deaths worldwide. The Food and Drug Administration steps up next week with national priority vouchers for three psychedelics, slashing approval times from months to weeks first time ever for these drugs, and clearing paths for the inaugural human trials of iBegaine right here in the United States. This bipartisan back shift could legitimize the French therapy, draw more funding in state

1:03level action while clinics keep monitoring hearts. Closely, if it pans out, it might transform lives stuck in addiction and trauma cycles. That's the story for today. California News Today, Driven by AI, I'm Cory with the Story.